Marquette Asset Management »

Zentalis Pharmaceuticals shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $141k 29k 4.85

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Rus 1000 Val Etf (IWD)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Rus 1000 Grw Etf (IWF)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Meta Platforms Cl A (META)
Dimensional Etf Trust Us Small Cap Etf (DFSV)

View all positions for Marquette Asset Management

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Acadian Asset Management
Vanguard Capital Management
Renaissance Technologies
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals